Qian Chang , Kaihao Ma , Guanyu Tan , Jianzhi Mao , Qiwei Tian , Yuanjie Zhu , Shiping Yang , Lu An
{"title":"透明质酸修饰Fe3O4对银屑病样皮肤增生的磁靶向光热抑制作用","authors":"Qian Chang , Kaihao Ma , Guanyu Tan , Jianzhi Mao , Qiwei Tian , Yuanjie Zhu , Shiping Yang , Lu An","doi":"10.1016/j.colsurfb.2025.114985","DOIUrl":null,"url":null,"abstract":"<div><div>Photothermal therapy (PTT) shows promise as an emerging treatment for psoriasis; however, its efficacy may be limited by insufficient concentrations of photothermal agents at the targeted sites. Herein, we devised a magnetic targeting enhanced strategy for alleviate psoriasiform keratinocyte proliferation by hyaluronic acid-iron oxide (Fe<sub>3</sub>O<sub>4</sub>@HA) nanocomposites. The synthesized Fe<sub>3</sub>O<sub>4</sub>@HA exhibit strong ferromagnetism and near infrared absorption, allowing it to magnetic targeting capabilities to selectively accumulate in magnetic control regions for site-specific PTT. A significant increase of up to 10 °C within the magnetic field region, highlighting exceptional both magnetic-targeted and photothermal properties of Fe<sub>3</sub>O<sub>4</sub>@HA. The murine model for psoriasis treatment further confirms the efficient accumulation of Fe<sub>3</sub>O<sub>4</sub>@HA in the diseased area by magnetic targeting, and elevated temperatures induced by site-specific near-infrared light irradiation can induce cell apoptosis, thus underscoring the potential therapeutic efficacy of Fe<sub>3</sub>O<sub>4</sub>@HA for psoriasis. This strategy offers a promising approach for the relief of psoriasis-related symptoms.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"256 ","pages":"Article 114985"},"PeriodicalIF":5.6000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hyaluronic acid-modified Fe3O4 for magnetic-targeted photothermal suppression of psoriasis-like skin hyperplasia\",\"authors\":\"Qian Chang , Kaihao Ma , Guanyu Tan , Jianzhi Mao , Qiwei Tian , Yuanjie Zhu , Shiping Yang , Lu An\",\"doi\":\"10.1016/j.colsurfb.2025.114985\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Photothermal therapy (PTT) shows promise as an emerging treatment for psoriasis; however, its efficacy may be limited by insufficient concentrations of photothermal agents at the targeted sites. Herein, we devised a magnetic targeting enhanced strategy for alleviate psoriasiform keratinocyte proliferation by hyaluronic acid-iron oxide (Fe<sub>3</sub>O<sub>4</sub>@HA) nanocomposites. The synthesized Fe<sub>3</sub>O<sub>4</sub>@HA exhibit strong ferromagnetism and near infrared absorption, allowing it to magnetic targeting capabilities to selectively accumulate in magnetic control regions for site-specific PTT. A significant increase of up to 10 °C within the magnetic field region, highlighting exceptional both magnetic-targeted and photothermal properties of Fe<sub>3</sub>O<sub>4</sub>@HA. The murine model for psoriasis treatment further confirms the efficient accumulation of Fe<sub>3</sub>O<sub>4</sub>@HA in the diseased area by magnetic targeting, and elevated temperatures induced by site-specific near-infrared light irradiation can induce cell apoptosis, thus underscoring the potential therapeutic efficacy of Fe<sub>3</sub>O<sub>4</sub>@HA for psoriasis. This strategy offers a promising approach for the relief of psoriasis-related symptoms.</div></div>\",\"PeriodicalId\":279,\"journal\":{\"name\":\"Colloids and Surfaces B: Biointerfaces\",\"volume\":\"256 \",\"pages\":\"Article 114985\"},\"PeriodicalIF\":5.6000,\"publicationDate\":\"2025-07-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Colloids and Surfaces B: Biointerfaces\",\"FirstCategoryId\":\"1\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0927776525004928\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOPHYSICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Colloids and Surfaces B: Biointerfaces","FirstCategoryId":"1","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0927776525004928","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOPHYSICS","Score":null,"Total":0}
Hyaluronic acid-modified Fe3O4 for magnetic-targeted photothermal suppression of psoriasis-like skin hyperplasia
Photothermal therapy (PTT) shows promise as an emerging treatment for psoriasis; however, its efficacy may be limited by insufficient concentrations of photothermal agents at the targeted sites. Herein, we devised a magnetic targeting enhanced strategy for alleviate psoriasiform keratinocyte proliferation by hyaluronic acid-iron oxide (Fe3O4@HA) nanocomposites. The synthesized Fe3O4@HA exhibit strong ferromagnetism and near infrared absorption, allowing it to magnetic targeting capabilities to selectively accumulate in magnetic control regions for site-specific PTT. A significant increase of up to 10 °C within the magnetic field region, highlighting exceptional both magnetic-targeted and photothermal properties of Fe3O4@HA. The murine model for psoriasis treatment further confirms the efficient accumulation of Fe3O4@HA in the diseased area by magnetic targeting, and elevated temperatures induced by site-specific near-infrared light irradiation can induce cell apoptosis, thus underscoring the potential therapeutic efficacy of Fe3O4@HA for psoriasis. This strategy offers a promising approach for the relief of psoriasis-related symptoms.
期刊介绍:
Colloids and Surfaces B: Biointerfaces is an international journal devoted to fundamental and applied research on colloid and interfacial phenomena in relation to systems of biological origin, having particular relevance to the medical, pharmaceutical, biotechnological, food and cosmetic fields.
Submissions that: (1) deal solely with biological phenomena and do not describe the physico-chemical or colloid-chemical background and/or mechanism of the phenomena, and (2) deal solely with colloid/interfacial phenomena and do not have appropriate biological content or relevance, are outside the scope of the journal and will not be considered for publication.
The journal publishes regular research papers, reviews, short communications and invited perspective articles, called BioInterface Perspectives. The BioInterface Perspective provide researchers the opportunity to review their own work, as well as provide insight into the work of others that inspired and influenced the author. Regular articles should have a maximum total length of 6,000 words. In addition, a (combined) maximum of 8 normal-sized figures and/or tables is allowed (so for instance 3 tables and 5 figures). For multiple-panel figures each set of two panels equates to one figure. Short communications should not exceed half of the above. It is required to give on the article cover page a short statistical summary of the article listing the total number of words and tables/figures.